Back to search
FDAFDA · Food and drugs·Recall number D-1282-2020

Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC: 0054-0415-25.

Published May 27, 2020 · Recall initiated: May 13, 2020

Summary

FDA records drug Class III recall D-1282-2020, published May 27, 2020 and initiated May 13, 2020. Recalling firm: West-Ward Columbus Inc; Status: Terminated; Reported quantity: 3336 Bottles; Lot: Lot #: AA4424A, Exp. 07/31/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
West-Ward Columbus Inc
Distributor
Nationwide in the US
Lot
Lot #: AA4424A, Exp. 07/31/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC: 0054-0415-25. recalled?

Yes. FDA published recall D-1282-2020 on May 27, 2020. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.

What should I do if I have this product?

Voluntary: Firm initiated · Letter